期刊文献+

一种强力霉素关键中间体的合成研究

Synthesis of the key intermediate of doxycycline
下载PDF
导出
摘要 11α-氯代甲烯土霉素是合成强力霉素的关键中间体。本文以N-氯代乙酰苯胺和土霉素为起始原料,经氯代、脱水、成盐三步反应得到目标化合物,其结构经核磁共振氢谱、红外光谱确认,总收率达82.2%。本合成方法中所用新脱水剂的环境污染小、对设备腐蚀小、产品收率高,更适于工业化推广。 The key intermediate of doxycycline,11α-chloro-metacycline,was synthesized from N-chloro acetanilide and oxytetracycline in three steps including chlorination,dehydration and salification.The structure of the intermediate was characterized by 1H NMR and HRMS.The overall yield of the synthetic route was 82.2%.The new dehydrant used in this method had the advantages of less pollution,lower corrosion and higher yield compared with anhydrous hydrogen fluoride,and it was more suitable for industrial application.
作者 徐桂清 高原 吴斗灿 毛龙飞 姜玉钦 李伟 XU Gui-qing;GAO Yuan;WU Dou-can;MAO Long-fei;JIANG Yu-qin;LI Wei(School of Chemistry and Chemical Engineering,Henan Normal University,Henan Engineering Research Center ofChiral Hydroxyl Pharmaceutical,Collaborative Innovation Centre of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions,Ministry of Ed;Hennan Ziweixing Chemistry Co.Ltd.,Xinxiang 4453011,China)
出处 《化学研究与应用》 CAS CSCD 北大核心 2018年第8期1354-1357,共4页 Chemical Research and Application
基金 河南省科技创新杰出青年基金项目(164100510015)资助。
关键词 强力霉素 关键中间体 合成 doxycycline key intermediate synthesis
  • 相关文献

参考文献2

二级参考文献11

  • 1孙保存,张诗武,齐丽莎,张丹芳,郭华,赵秀兰.内皮抑素和多西环素抑制黑色素瘤浸润转移相关蛋白表达的研究[J].中华病理学杂志,2006,35(11):677-680. 被引量:7
  • 2上海市科学技术交流站组.正交试验设计法[M].上海:上海人民出版社,1975.219-229.
  • 3Curran S, Murray GI. Matrix metalloproteinases : molecular aspects of their rules in tumor invasion and metastasis [J].Eur J Cancer,2000 ; 36 ( 13 ) : 1621-30.
  • 4Lambert E, Dasse E, Haye B, et al. TIMPs as multifacial proteins[J]. Crit Rev Oncol Hematol, 2004 ;49 ( 3 ) : 187-98.
  • 5Mendes O, Kim HT, Stoica G. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model[J]. Clin Exp Met,2005 ;22 (3) :237-46.
  • 6Kamat AA, Fletcher M, Gruman LM ,et al. The clinical relevance of stromal matrix metalloproteinases expression in ovarian cancer [J]. Clin Cancer Res,2006 ; 12 ( 6 ) : 1707-14.
  • 7Overall CE, Kleifeld O. Tumor microenvironment-opinion : validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy [J]. Nat Rev Cancer, 2006 ; 6 ( 3 ) : 227-39.
  • 8Sakata K, Shigenmasa K, Nagai N ,et al. Expression of matrix metalloproteinases ( MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-I,TIMP-2) in common epithelial of the ovary[J].Int J Oncol,2000; 17 (4) :673-81.
  • 9Lokeshwar BL. MMP inhibition in prostate cancer [J].Ann N Y Acad Sci, 1999 ;878 (30) :271-89.
  • 10Seftor RE, Seftor EA, Kirschmann DA, et al. Targeting the tumor microen- vironment with chemically modified tetracyclines inhibition of lamin in 5 ganmm 2 chain promigratory fragments and vasculogenic minicry[J]. Mol Cancer Ther,2002 ; 1 ( 13 ) : 1173-9.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部